GRPH Old Financials

Based on the measurements of operating efficiency obtained from GRPH Old's historical financial statements, GRPH Old is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
  
Understanding current and past GRPH Old Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GRPH Old's financial statements are interrelated, with each one affecting the others. For example, an increase in GRPH Old's assets may result in an increase in income on the income statement.

GRPH Old Stock Summary

GRPH Old competes with Assembly Biosciences, Instil Bio, Nuvation Bio, Achilles Therapeutics, and NextCure. Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. Graphite Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 111 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address611 Gateway Boulevard,
New SymbolLENZ
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitegraphitebio.com
Phone650 484 0886
CurrencyUSD - US Dollar

GRPH Old Key Financial Ratios

GRPH Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GRPH Old's current stock value. Our valuation model uses many indicators to compare GRPH Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GRPH Old competition to find correlations between indicators driving GRPH Old's intrinsic value. More Info.
GRPH Old is rated # 5 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GRPH Old's earnings, one of the primary drivers of an investment's value.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in GRPH Stock

If you are still planning to invest in GRPH Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GRPH Old's history and understand the potential risks before investing.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities